SARS-CoV-2 rapid antigen test clinical collaboration
Avacta and Liverpool School of Tropical Medicine collaborate to clinically validate saliva-based rapid coronavirus test being developed with Cytiva
Avacta and Liverpool School of Tropical Medicine collaborate to clinically validate saliva-based rapid coronavirus test being developed with Cytiva
A University of Bern international research team has succeeded in developing an electrocatalyst for hydrogen fuel cells
Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%
First participants dosed in trial of AZD7442 to assess safety, tolerability and pharmacokinetics of the combination
Thermo Fisher’s cloud services enable easy, cost-effective, compliant and secure cloud deployment of Thermo Scientific SampleManager LIMS software
The Thermo Scientific Smart-Vue Pro Remote Monitoring Solution protects samples, improves laboratory efficiency and facilitates regulatory compliance
Innovative online tool, and new consumables kits provide pioneering solutions for faster set up and analysis
Workflow is quick, simple and scalable for high-throughput antibody detection with high PPA sensitivity and NPA specificity
Second manufacturing expansion will help meet global demand for research, clinical and GMP grade raw materials as well as research and clinical-grade APIs to include mRNA, self-amplifying RNA and plasmid DNA
Supports cross-functional teams of chemists and biologists developing non-natural, chemically modified therapeutics for drug discovery
Researchers at the University of Bern have now discovered which genes play an important role in the response to radiation therapy
A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK as early as autumn, thanks to a £1.9million award from the UK government
The overall goal is to continue to detect and discover critical components in the overall cellular response to COVID-19